Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Agnosia × Electroacupuncture × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Neoplasms 5 Pain 4 Sleep Initiation and Maintenance Disorders 3 Prostatic Neoplasms 3 Vomiting 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Nausea 2 Depression 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Anxiety Disorders 2 Acupuncture 2 Xerostomia 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Prostatic Hyperplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Ileus 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Opioid-Induced Constipation 1 Obesity, Abdominal 1 Obesity 1 Neuropathy, Painful 1 Neuralgia 1

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Analgesics, Opioid 7 Ropivacaine 6 Anesthesia, General 6 Acetaminophen 6 Lidocaine 5 Fentanyl 5 Acupuncture Therapy 5 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Morphine 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 Transcutaneous Electric Nerve Stimulation 2 Tea 2 Pregabalin 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04917796 2026-01-30

ACT

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Neuropathy, Painful, Agnosia, Neuralgia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡